author-photo

Majid Ghoddusi

Novartis

16

Papers

236

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

123 P-MUC1C-ALLO1: A fully allogeneic stem cell memory T cell (TSCM) CAR-T therapy with broad potential in solid tumor

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?

2021
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (29)
Abstract 1682: Development and activity of a novel antibody-drug conjugate for the treatment of P-cadherin expressing cancers

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Abstract LB-61: Vemurafenib promotes RAS wild-type tumor formation in a mouse model of HPV-driven cutaneous squamous cell carcinoma.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (42)
Abstract B129: RAF inhibition promotes tumorigenesis in a mouse model of HPV-driven squamous cell carcinoma.

2011 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)